Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators

Quality of Life Research

Volumn 19, Issue 3, 2010, Pages 307-315

  Kao, Chi Wen ^a   Friedmann, Erika ^b   Thomas, Sue A ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

Antiarrhythmia versus implanted defibrillator clinical trial; Implantable cardioverter defibrillator; Predictor; Quality of life; Survival

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; MIDDLE AGED; MORTALITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SICKNESS IMPACT PROFILE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS;

EID: 77952552213     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-010-9596-6     Document Type: Article

References (57)

1. Zheng, Z. J., Croft, J. B., Giles, W. H., et al. (2001). Sudden cardiac death in the United States, 1989 to 1998. Circulation, 104, 2158-2163.
2. Fetzer, S. J. (2003). The patient with an implantable cardioverter defibrillator. Journal of PeriAnesthesia Nursing, 18, 398-405.
3. Josephson, M., & Wellens, H. J. J. (2004). Implantable defibrillators and sudden cardiac death. Circulation, 109, 2685-2691.
4. Barron, H. V., Khan, H. H., Viskin, S., et al. (1997). Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. The American Journal of Cardiology, 79, 1180-1184.
5. Gomes, J. A., Mehta, D., Winters, S. L., et al. (1997). Predictors of long-term survival in patients with malignant ventricular arrhythmias. The American Journal of Cardiology, 79, 1054-1060.
6. Connolly, S. J., Gent, M., Roberts, R. S., et al. (2000). Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 101, 1297-1302.
7. Sandner, S. E., Wieselthaler, G., Zuckermann, A., et al. (2001). Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation. Circulation, 104, I171-I176.
8. Ezekowitz, J. A., Armstrong, P. W., & McAlister, F. A. (2003). Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Annals of Internal Medicine, 138, 445-452.
9. Eckert, M., & Jones, T. (2002). How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families? International Journal of Nursing Practice, 8, 152-157.
10. Kamphuis, H. C. M., Verhoeven, N. W. J. M., de Leeuw, R., et al. (2004). ICD: A qualitative study of patient experience the first year after implantation. Journal of Clinical Nursing, 13, 1008-1016.
11. Bouvy, M. L., Heerdink, E. R., Leufkens, H. G. M., et al. (2003). Predicting mortality in patients with heart failure: A pragmatic approach. Heart, 89, 605-609.
12. Rodriguez-Artalejo, F., Guallar-Castillon, P., Rodriguez-Pascual, C., et al. (2005). Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Archivement of Internal Medicine, 165, 1274-1279.
13. Westin, L., Nilstun, T., Carlsson, R., et al. (2005). Patients with ischemic heart disease: quality of life predicts long-term mortality. Scandinavian Cardiovascular Journal, 39, 50-54.
14. Spertus, J. A., Jones, P., McDonell, M., et al. (2002). Health status predicts long-term outcome in outpatients with coronary disease. Circulation, 106, 43-49.
15. Rumsfeld, J., MaWhinney, S., McCarthy, M., et al. (1999). Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Journal of the American Medical Association, 281, 1298-1303.
16. Levine, J. H., Mellits, D., Baumgardner, R. A., et al. (1991). Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation, 84, 558-566.
17. Grimm, W., Flores, B. T., & Marchlinski, F. E. (1993). Shock occurrence and survival in 241 patients with implantable cardioverter- defibrillator therapy. Circulation, 87, 1880-1888.
18. Nath, S., DeLacey, W. A., Haines, D. E., et al. (1993). Use of a regional wall motion score to enhance risk stratification of patients receiving an implantable cardioverter-defibrillator. Journal of American College of Cardiology, 22, 1093-1099.
19. Lessmeier, T. J., Lehmann, M. H., Steinman, R. T., et al. (1994). Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. American Heart Journal, 128, 211-218.
20. Villacastin, J., Almedral, J., Arenal, A., et al. (1996). Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharge in patients with implanted cardioverterdefibrillators. Circulation, 93, 753-762.
21. Anvari, A., Gottsauner-Wolf, M., Tiirel, Z., et al. (1998). Predictors of outcome in patients with implantable cardioverter defibrillators. Cardiology, 90, 180-186.
22. Narasimban, C., Dhala, A., Axtell, K., et al. (1997). Comparison of outcome of implantable cardioverter-defibrillator implantation in patients with severe versus moderately severe left ventricular dysfunction secondary to atherosclerotic coronary artery disease. American Journal of Cardiology, 80, 1305-1308.
23. Elhendy, A., Chapman, S., Porter, T. R., et al. (2005). Association of myocardial ischemia with mortality and implantable cardioverter-defibrillator therapy in patients with coronary artery disease at risk of arrhythmic death. Journal of the American College of Cardiology, 46, 1721-1726.
24. Chevalier, P., Verrier, P., Kirkorian, G., et al. (1996). Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator. Psychotherapy and Psychosomatics, 65, 49-56.
25. Hegel, M. T., Griegel, L. E., Black, C., et al. (1997). Anxiety and depression in patients receiving implanted cardioverter-defibrillators: A longitudinal investigation. International Journal of Psychiatry in Medicine, 27, 57-69.
26. Schuster, P. M., Phillips, S., Dillon, D. L., et al. (1998). The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator. Rehabilitation Nursing, 23, 30-37.
27. Sears, S. F., & Conti, J. B. (2003). Quality of life and psychological functions of ICD patients. Heart, 87, 488-493.
28. AVID investigators. (1997). A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576-1583.
29. AVID investigators (2000). Antiarrhythmics versus implantable defibrillators trial: 2000 preliminary dataset. Retrived 02 August 2003, from http://www.nhlbi.nih.gov/resources/deca/avid/contents.pdf.
30. Geller, N. L., Sorlie, P., Coady, S., et al. (2004). Limited access data sets from studies funded by the National Heart, Lung, and Blood Institute. Clinical Trials, 1, 517-524.
31. Wolinsky, F. D., Wyrwich, K. W., Nienaber, N. A., et al. (1998). Generic versus disease-specific health status measures: an example using coronary artery disease and congestive heart failure patients. Evaluation & The Health Professions, 21, 216-243.
32. Ware, J. E. (2000). SF-36 health survey update. Spine, 25, 3130-3139.
33. Ware, J. E., & Kosinski, M. (2001). Physical & mental health summary scales: A manual for users of version 1 (2nd ed.). RI: QualityMetric Incorporated.
34. Ferrans, C. E., & Powers,M. J. (1992). Psychometric assessment of the quality of life index. Research in Nursing and Health, 15, 29-38.
35. Bainger, E. M., & Fernsler, J. I. (1995). Perceived quality of life before and after implantation of an internal cardioverter defibrillator. American Journal of Critical Care, 4, 36-43.
36. Delunas, L. R., & Potempa, K. (1999). Adaptation after treatment for heart disease: Preliminary examination within a stress appraisal context. Heart and Lung, 28, 186-194.
37. Skaggs, B. G., & Cristopherson, B. (1999). Quality of life comparisons after coronary angioplasty and coronary artery bypass graft surgery. Heart and Lung, 28, 409-416.
38. Hosmer, D. W., & Lemeshow, S. (1989). Applied logistic regression. UK: Wiley.
39. Greenland, S. (1989). Modeling and variable selection in epidemiologic analysis. American Journal of Public Health, 79, 340-349.
40. Flemme, I., Edvardsson, N., Hinic, H., et al. (2005). Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator. Heart and Lung, 34, 386-392.
41. Sossong, A. (2007). Living with an implantable cardioverter defibrillator: Patient outcomes and the nurse's role. Journal of Cardiovascular Nursing, 22, 99-104.
42. Arteaga, W. J., & Windle, J. R. (1995). The quality of life of patients with life-threatening arrhythmias. Archives of Internal Medicine, 155, 2086-2091.
43. Herrmann, C., Muhen, F., Schaumann, A., et al. (1997). Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. PACE, 20, 95-103.
44. Herbst, J. H., Goofman, M., Feldstein, S., et al. (1999). Healthrelated quality-of-life assessment of patients with life-threatening ventricular arrhythmias. PACE, 22, 915-926.
45. Namerow, P. B., Firth, B. R., Heywood, G. M., et al. (1999). Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings from the CABG patch trial. PACE, 22, 1305-1313.
46. Duru, F., Buchi, S., Klaghofer, R., et al. (2001). How different from pacemaker patients are recipients of implantable cardioverter-defibrillators with respect to psychosocial adaptation, affective disorders, and quality of life? Heart, 85, 375-379.
47. Irvine, J., Dorian, P., Baker, B., et al. (2002). Quality of life in the Canadian implantable defibrillator study (CIDS). American Heart Journal, 144, 282-289.
48. Kuhlkamp, V. (2002). Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. Journal of the American College of Cardiology, 39, 790-797.
49. Newman, D. M., Dorian, P., Paquette, M., et al. (2003). Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. American Heart Journal, 145, 841-846.
50. Carroll, D. L., & Hamilton, G. A. (2005). Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart and Lung, 34, 169-178.
51. Flemme, I., Bolse, K., Ivarsson, A., et al. (2001). Life situation of patients with an implantable cardioverter defibrillator: A descriptive longitudinal study. Journal of Clinical Nursing, 10, 563-572.
52. Godemann, F., Butter, C., Lampe, F., et al. (2004). Determinants of the quality of life in patients with an implantable cardioverter defibrillator. Quality of Life Research, 13, 411-416.
53. Kuck, K. H., Cappato, R., Siebels, J., et al. (2000). CASH investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation, 102, 748-754.
54. Moss, A. J., Hall, J., Cannon, D. S., et al. (1996). Improved survival with implanted defibrillator on ventricular arrhythmia. New England Journal of Medicine, 335, 1933-1940
55. Chakko, S., Marchena, E., Kessler, K. M., et al. (1989). Ventricular arrhythmias in congestive heart failure. Clinical Cardiology, 12, 525-530.
56. Steinberg, J. S., Joshi, S., Schron, E. B., et al. (2008). Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm, 5, 361-365.
57. Schron, E. B., Exner, D. V., Yao, Q., et al. (2002). Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation, 105, 589-594